๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Is it safe to stop lamivudine after the emergence of YMDD mutants during lamivudine therapy for chronic hepatitis B?

โœ Scribed by V.W.S. Wong; H.L.Y. Chan; M.L. Wong; Nancy Leung

Book ID
118565542
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
97 KB
Volume
36
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Emergence and takeover of precore-stop m
Emergence and takeover of precore-stop mutant prior to exacerbation of e antigen-negative chronic hepatitis B after withdrawal of lamivudine therapy
โœ Chau-Ting Yeh; Wei-Pin Lin; Chao-Wei Hsu; Ming-Ling Chang; Shi-Ming Lin; I-Shyan ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 149 KB

Although hepatitis B virus (HBV) precore-stop mutant (nonsense mutation at codon 28) is usually isolated from patients with hepatitis B e antigen (HBeAg)-negative hepatitis, it is unclear whether the mutant is the cause of the hepatitis flare or it is a consequence of necroinflammation. Using the am

Emergence and takeover of YMDD motif mut
Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy
โœ Kazuaki Chayama; Yoshiyuki Suzuki; Masahiro Kobayashi; Mizuho Kobayashi; Akihito ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 165 KB ๐Ÿ‘ 1 views

Treatment of hepatitis B virus (HBV) with lamivudine is effective in suppressing virus replication and results in reduced inflammatory activity. However, the emergence of lamivudine-resistant mutant virus, with amino acid substitution in the YMDD motif of DNA polymerase, has been reported. We report